Cargando…
Risk of Chronic Obstructive Pulmonary Disease Exacerbation in Patients Who Use Methotrexate—A Nationwide Study of 58,580 Outpatients
Patients with severe chronic obstructive pulmonary disease (COPD) experience frequent acute exacerbations and require repeated courses of corticosteroid therapy, which may lead to adverse effects. Methotrexate (MTX) has anti-inflammatory properties. The objective of this study was to describe the ri...
Autores principales: | Bergsøe, Christina Marisa, Sivapalan, Pradeesh, Saeed, Mohamad Isam, Eklöf, Josefin, Saghir, Zaigham, Sørensen, Rikke, Biering-Sørensen, Tor, Jensen, Jens-Ulrik Stæhr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229017/ https://www.ncbi.nlm.nih.gov/pubmed/34073252 http://dx.doi.org/10.3390/biomedicines9060604 |
Ejemplares similares
-
Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations
por: Alispahic, Imane Achir, et al.
Publicado: (2020) -
The Impact of Social Distancing in 2020 on Admission Rates for Exacerbations in Asthma: A Nationwide Cohort Study
por: Toennesen, Louise Lindhardt, et al.
Publicado: (2022) -
Risk of Malignancy in Patients with Asthma-COPD Overlap Compared to Patients with COPD without Asthma
por: Bonnesen, Barbara, et al.
Publicado: (2022) -
The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD—A Nationwide Cohort Study of 49,500 Patients
por: Jordan, Alexander, et al.
Publicado: (2021) -
Major cardiovascular events in patients with severe COPD with and without asthma: a nationwide cohort study
por: Bonnesen, Barbara, et al.
Publicado: (2022)